DYSGERMINOMA

Clinical trials for DYSGERMINOMA explained in plain language.

Never miss a new study

Get alerted when new DYSGERMINOMA trials appear

Sign up with your email to follow new studies for DYSGERMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immunotherapy duo takes on stubborn germ cell tumors

Disease control Ongoing

This study tests two immunotherapy drugs, durvalumab and tremelimumab, in 30 adults with germ cell tumors that have come back or not responded to standard treatment. The goal is to see if the combination can shrink tumors and control the disease. Participants must have measurable…

Matched conditions: DYSGERMINOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 26, 2026 11:05 UTC

DYSGERMINOMA

Get alerted when new DYSGERMINOMA trials appear

Immunotherapy duo takes on stubborn germ cell tumors